Heart Failure With Preserved Ejection Fraction: Common, Serious, and Treatable
Industry Podcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit
Although heart failure with preserved ejection fraction (HFpEF) is common and increasing in prevalence, persistent misconceptions, including a perceived lack of therapeutic options, limit its effective management.1,2 In this episode, featuring cardiologist Dr. John Ryan of the University of Utah, we will counteract these misconceptions through exploration of various HFpEF patient profiles, covering key aspects of HFpEF diagnosis and optimal management in inpatient and outpatient settings.
John J. Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA
Director, Pulmonary Hypertension Comprehensive Care Center, University of Utah Hospital
Medical Director, Cardiovascular Medical Unit, University of Utah Hospital
Faculty Director of Cardiology Education, University of Utah School of Medicine
This podcast is nonpromotional and is intended to provide disease-state education rather than information on specific products or therapies. The podcast was sponsored by the Novartis Pharmaceuticals Corporation, and the speakers were compensated for their time. The statements in the podcast reflect the medical expertise and opinions of the presenters.